Abstract Body

Background

Intestinal inflammation persists in HIV and contributes to immune activation. Bile acids, which are metabolized by gut bacteria, function primarily in digestion but have increasingly appreciated roles in immune regulation. Bile acids can have anti-inflammatory effects via signaling through the nuclear farnesoid X receptor (FXR) and membrane Takeda G protein-coupled receptor 5 (TGR5). The role of bile acids in regulating inflammation in HIV is not known. We hypothesized that the altered gut environment in HIV may affect bile acid metabolism and contribute to persistent inflammation.

Methods

We obtained paired plasma and gut tissue samples from persons with (PWH) and without HIV (PWOH) to examine plasma bile acid composition, bile acid receptor expression in the gut, and inflammation. Plasma bile acids were measured using targeted liquid chromatography-mass spectrometry and immune biomarkers quantified with Meso Scale assays. Bile acid receptors FXR and TGR5 were quantified in gut tissue by qRT-PCR and immunohistochemistry with digital image analysis to localize receptor expression. Intestinal inflammation was assessed by histopathology.

Results

The study included 52 persons; 21 PWH and 31 PWOH. The PWH were older (mean 47 vs 40 years; p=0.04) and included more men (90% vs 62%, p=0.03) than the PWOH. Initial analyses showed decreased primary bile acids cholic acid (p=0.04) and chenodeoxycholic acid (p=0.007) in HIV, as well as decreased secondary bile acids deoxycholic acid (p=0.03), glycodeoxycholic acid (p=0.04), and ursodeoxycholic acid (p=0.04). Adjusted analysis showed that antiretroviral therapy, particularly protease inhibitors, may be a significant contributor to bile acid alterations. There was no difference in FXR expression in the gut, but PWH had higher TGR5 expression (p<0.001). Moreover, PWH had higher membrane than cytoplasmic TGR5 (p=0.03) which correlated with intestinal inflammation histopathology scores (r=0.56, p=0.004). Integrative analysis showed that bile acids negatively correlated with FABP2 and IL-22, markers of intestinal barrier dysfunction.

Conclusions

PWH had decreased plasma primary and secondary bile acids, potentially due to alterations in synthesis and/or metabolism by gut bacteria. In addition, PWH had higher membrane TGR5 expression in the gut which correlated with intestinal inflammation. This suggests that reduced anti-inflammatory bile acid signaling may be one potential mechanism contributing to ongoing inflammation in HIV.